Results 121 to 130 of about 12,391,565 (386)

Clonality, trafficking, and molecular alterations among Hprt mutant T lymphocytes isolated from control mice versus mice treated with N‐ethyl‐N‐nitrosourea [PDF]

, 2023
Stephen A. Judice, Hillary E. Sussman, Dale M. Walker, John P. O’Neill, Richard J. Albertini, Vernon E. Walker   +5 more
openalex   +1 more source

EFEKTIVITAS EKSTRAK KULIT MANGGIS(Garcinia mangostana) TERHADAP JUMLAH LIMFOSIT T CD4+ DAN KADAR IL-2 PADA PENDERITA HIV DENGAN TERAPI ANTIRETROVIRAL [PDF]

, 2015
Background : HIV attacks human’s CD4+ T lymphocytes immunity system. IL-2 initiate cell cycle progression and CD4 T Lymphocytes proliferation. IL-2 becoming Indicator of immunity system repair within HIV infection2. HIV patients under ARV medication with
Amanah, Amanah
core  

Antigen-Specific Polyclonal Cytotoxic T Lymphocytes Induced by Fusions of Dendritic Cells and Tumor Cells [PDF]

, 2010
The aim of cancer vaccines is induction of tumor-specific cytotoxic T lymphocytes (CTLs) that can reduce the tumor mass. Dendritic cells (DCs) are potent antigen-presenting cells and play a central role in the initiation and regulation of primary immune ...
Gong, Jianlin, Hara, Eiichi, Homma, Sadamu, Koido, Shigeo, Namiki, Yoshihisa, Ohkusa, Toshifumi, Tajiri, Hisao   +6 more
core   +5 more sources

Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo, Deyou Peng, Zhouao Zhang, Mingjin Yang, Xinyan Guo, Tianyu Ma, Xiaoyu Huang, Mingming Xu, Linlin Fu, Yong Zhang   +9 more
wiley   +1 more source

Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes

Journal of Experimental Medicine, 1996
A human receptor that is selective for the CXC chemokines IP10 and Mig was cloned and characterized. The receptor cDNA has an open reading frame of 1104-bp encoding a protein of 368 amino acids with a molecular mass of 40,659 dalton.
M. Loetscher, B. Gerber, P. Loetscher, Simon A. Jones, L. Piali, I. Clark‐Lewis, M. Baggiolini, B. Moser   +7 more
semanticscholar   +1 more source

Time Trends and Predictors of Gout Remission Over 6 Years

Arthritis Care &Research, EarlyView.
Objective This study aims to describe the trends in remission rates over 6 years of follow‐up among people with gout taking urate‐lowering therapy (ULT) and to identify variables that predict remission. Methods A post hoc analysis was conducted using data from the Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout (CARES) trial ...
Adwoa Dansoa Tabi‐Amponsah, Sarah Stewart, Greg Gamble, Lisa K. Stamp, William J. Taylor, Nicola Dalbeth   +5 more
wiley   +1 more source

HLA Class II Antibody Activation of Endothelial Cells Promotes Th17 and Disrupts Regulatory T Lymphocyte Expansion [PDF]

, 2015
Julien Lion, Cécile Taflin, Amy Cross, Macarena Robledo-Sarmiento, Elena Mariotto, Alain Savenay, M. Carmagnat, Caroline Suberbielle, Dominique Charron, Alain Haziot, Denis Glotz, Nuala Mooney   +11 more
openalex   +1 more source

Transcriptional Reprogramming of Mature CD4+ T helper Cells generates distinct MHC class II-restricted Cytotoxic T Lymphocytes

Nature Immunology, 2013
TCRαβ thymocytes differentiate into either CD8αβ+ cytotoxic T lymphocytes or CD4+ helper T cells. This functional dichotomy is controlled by key transcription factors, including the helper T cell master regulator ThPOK, which suppresses the cytolytic ...
D. Mucida, M. M. Husain, Sawako Muroi, F. van Wijk, Ryo Shinnakasu, Y. Naoe, B. Reis, Yujun Huang, F. Lambolez, Michael Docherty, A. Attinger, J. Shui, Gisen Kim, C. Lena, S. Sakaguchi, Chizuko Miyamoto, Peng Wang, K. Atarashi, Yunji Park, T. Nakayama, K. Honda, W. Ellmeier, M. Kronenberg, I. Taniuchi, H. Cheroutre   +24 more
semanticscholar   +1 more source

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial

Arthritis Care &Research, Accepted Article.
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; NCT04179032) used three‐weight‐band ...
Hermine I. Brunner, Jordi Antón, Inmaculada Calvo‐Penadés, Richard Dimelow, Gerd Horneff, Sylvia Kamphuis, Rebecca Marino, Andre van Maurik, Kirsten Minden, Masaaki Mori, Josephine Ocran‐Appiah, Christel Wilkinson, Yuichi Yamasaki, Deepak Assudani, for the Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology International Trials Organisation (PRINTO) network investigators   +14 more
wiley   +1 more source

Predicting the efficacy of anti-B-cell therapy in patients with multiple sclerosis [PDF]

Анналы клинической и экспериментальной неврологии
Introduction. Prognostic markers can be used to evaluate a response to anti-B-cell therapy in patients with multiple sclerosis (MS). Aim. The study aimed to evaluate the characteristics of peripheral blood (PB) lymphocytes and monocytes in patients ...
Yuliana A. Belova, Yulia Yu. Chuksina, Sergey V. Kotov   +2 more
doaj   +1 more source